Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vera Therapeutics (VERA – Research Report) on September 13 and set a price target of $50.00. The company’s shares closed last Friday ...

18, 2024 (GLOBE NEWSWIRE) -- Pharmacosmos A/S, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, and G1 Therapeutics, Inc.

(RTTNews) - Achilles Therapeutics plc (ACHL) Thursday announced the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical trials. The company will ...

DALLAS, Sept. 19, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases (IRDs) and geographic atrophy ...

MANCHESTER, England, Sept. 17, 2024 /PRNewswire/ -- Monument Therapeutics, a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology ...

The Wyss Institute at Harvard University announced today that Ropirio Therapeutics ... the molecular underpinnings of human biology in order to create effective treatments for diseases.

18, 2024 (GLOBE NEWSWIRE) -- Pharmacosmos A/S, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, and G1 Therapeutics ...

Optimizing iPSC differentiation significantly improves in vitro Alzheimer's disease models, leading to more accurate and ...